✅ New API: 6000+ US Stock Options End-of-Day Data with 40+ fields. Learn more

Hubei Biocause Pharmaceutical (000627 SHE) stock market data APIs

¥1.5727 0(0%)
as of September 17, 2025
Try our APIs with free plan!

Hubei Biocause Pharmaceutical Financial Data Overview

Price chart is built with Anychart
ISIN: CNE00000**** The data is available with plans that include the Fundamentals API. Check our pricing page for details.

Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. It also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, the company is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. It exports its products to approximately 85 countries, including the United States, the European Union, and internationally. The company is based in Jingmen, China.

Prev. Close 1.5727
Open 1.5727
High 1.5727
Low 1.5727
52 wk Range 1.35-5.42
Market Cap 7 749 M
Shares Outstanding 4 904 M
Revenue 40 698 M
EPS 0.0065
Beta 0.709

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Hubei Biocause Pharmaceutical (top by weight)

Ticker
100-day Price Change
Weight
VWO.US Vanguard FTSE Emerging Markets Index Fund ETF Shares
5.46 (11.19%)
0.00

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Hubei Biocause Pharmaceutical data using free add-ons & libraries


Get Hubei Biocause Pharmaceutical Fundamental Data

Hubei Biocause Pharmaceutical Fundamental data includes:

  • Net Revenue: 40 698 M
  • EBITDA: -2 037 982 848
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Hubei Biocause Pharmaceutical Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2024-09-30
  • EPS/Forecast: NaN
GET THE PACKAGE

Get Hubei Biocause Pharmaceutical End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE
Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat